A Phase 1 interventional study of EuNmCV-5 and Menveo in Infection, Meningococcal, sponsored by EuBiologics Co.,Ltd. Completed at 1 site in Korea, Republic of. Open to participants aged 19 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-20.
Sponsored by EuBiologics Co.,Ltd · Phase 1, Interventional, and Prevention
Phase I study to evaluate safety and immunogenicity in healthy adult subjects following a single dose administration of Meningococcal (Group A, C, W-135, X, and Y)-CRM197 Conjugate vaccine
243 studies on the registry are indexed under Meningococcal Infections; 8 are open to participants now.
This study's enrollment of 60 is below the median of 456 across 214 interventional studies indexed under Meningococcal Infections.
Browse Meningococcal Infections studies →EuBiologics Co.,Ltd is the lead sponsor of 14 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Healthy adults received 0.5mL single intramuscular dose on Day 0.
Biological: EuNmCV-5
Healthy adults received 0.5mL single intramuscular dose on Day 0.
Biological: Menveo
0.5mL single intramuscular dose on Day 0
Also known as: Meningococcal(Groups A, C, W-135, X, and Y) Conjugate Vaccine
0.5mL single intramuscular dose on Day 0
Also known as: Meningococcal(Groups A, C, Y, and W-135) Conjugate Vaccine
Occurrence of solicited adverse events
local and systemic AEs
Time frame: within 7 days post vaccination
Occurrence of unsolicited adverse events
Time frame: within 28 days post vaccination
Occurrence of serious adverse events
Time frame: within 180 days post vaccination
This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
EuBiologics Co.,Ltd